Funding Received
$20 Million in 1 Round from 6 Investors
Most Recent Funding
$20 Million Series A on May 16, 2006
Headquarters:
London
Description:
Viron Therapeutics, a clinical-stage biopharmaceutical company, develops viral proteins to treat and prevent human inflammatory disorders.
Categories:
Biotechnology
Website:
http://www.vironinc.com

Detailed Description

Update

Viron Therapeutics is a clinical stage biopharmaceutical company pioneering the development of viral proteins to treat and prevent human inflammatory disorders. Viral proteins represent a revolutionary new class of drugs. By harnessing the evolutionary power of viruses and other pathogens to evade the human body's protective inflammatory response, Viron is able to identify and develop powerful protein therapeutics that have distinct advantages in potency and efficacy over conventional drug therapy. Viron is the first company to successfully advance a viral protein drug into human testing.

Board Members and Advisors (1)

Update

Investors (6)

Update

Offices/Locations (1)

Update
  • Office

    700 Collip Circle, Suite 203

    Ontario

    London, N6G 4X8

    GBR

Images (1)

Update
  • F3afd647b1ab199822526b06bb569d77